Despite high levels of bioactive chemerin being found to exist in ascitic fluids of patients with ovarian carcinomas, to date, few studies have addressed its impact on the pathophysiology of ovarian cancer. The gene discussed is RARRES2; the disease is ovarian carcinoma.